Advancing a Non-Infectious Disease Indication Through Clinical Development
Time: 3:30 pm
day: Conference Day One
Details:
- Explore a clinical case study demonstrating how microbiome drug development is progressing for diseases beyond infectious
- Key milestones and challenges encountered to underscore efficacy demonstration in non-infectious targets
- Uncover patient outcomes and clinical markers demonstrating the therapeutic impact of microbiome modulation in a novel therapeutic context
